Picture of CONTRAFECT logo

CFRXQ CONTRAFECT Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for CONTRAFECT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-37.7-12.8-28.2-20.3-65.2
Depreciation
Non-Cash Items9.25-13.1-2.93-22.85.26
Unusual Items
Other Non-Cash Items
Changes in Working Capital2.02-1.71-2.271.7613.8
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-26.3-27.4-33.2-41.1-46
Capital Expenditures-0.133-0.0200-0.062
Purchase of Fixed Assets
Other Investing Cash Flow Items17.322-27.4-11.632.1
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities17.222-27.4-11.632.1
Financing Cash Flow Items-1.07-1.71-3.64-3.7-0.851
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities10.421.351.953.96.14
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.3315.9-8.71.17-7.75